Emerging Antimicrobials and Diagnostics in AMR (EADA)
The international matchmaking events ‘Emerging Antimicrobials and Diagnostics in AMR’ (EADA) aim to bring together global stakeholders involved in the research, development and commercialisation of emerging antimicrobials, diagnostics and related (platform) technologies.
EADA is facilated by AMR Insights partners. In 2022 these include Evotec, Antimicrobial Resistance Fighter Coalition, NYtor and Molzym.
The annual event was organised for the first time in 2019 and will be continued for the years to come.
Four successful events in 2018, 2019, 2020 and 2021.
For further information: firstname.lastname@example.org